General situation of the study object.

ObjectiveThe increase in vascular permeability and bleeding caused by systemic endothelial damage is the most basic pathological change of hemorrhagic fever with renal syndrome(HFRS) caused by Hantavirus, but there is a lack of early biomarkers to detect the severity and prognosis of HFRS. Soluble thrombomodulin (sTM) is a sensitive marker of endothelial damage. In this study we investigated the role of sTM in the evaluation of the severity and prognosis of HFRS patients.MethodsA retrospective analysis was conducted on 51 patients with HFRS treated in the Infectious Diseases Department of the Second Affiliated Hospital of Air Force Medical University from January 2023 to January 2024. We compared the changes of sTM among patients with HFRS in different phases and subtypes, and analyzed the correlation between sTM and related laboratory diagnostic indicators. Additionally, we evaluated the differences of sTM and related laboratory diagnostic indicators between survivors and non-survivors, and assessed the predictive ability of sTM for the mortality risk of HFRS patients based on the ROC curve, and determined the cut-off value of sTM.ResultsIn the HFRS phases, sTM increased during the febrile phase, reached its peak during the hypotensive phase, and decreased during the oliguria-dipuria phase. In the HFRS subtypes, there was no difference between the mild and moderate subtypes (P > 0.05), while in the moderate, severe, and critical subtypes, it showed a “stepwise” increase (P P P ConclusionsTM serves as a valuable biomarker for risk stratification and prognosis evaluation in HFRS.